Oxford AstraZeneca jabs effective against severe COVID new trial in US confirms Press Trust of India Mar 23, 2021 A large trial in the US and two South American countries of the Oxford-AstraZeneca vaccine has shown 79 per cent efficacy rate at…
CEO says AstraZeneca likely to run new global trial of COVID-19 vaccine Reuters Nov 27, 2020 AstraZeneca shot developed with Oxford University is cheaper to make, easier to distribute and faster to scale up than its rivals
